Jain Global’s Genmab GMAB Stock Holding History

Jain Global’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-35,281	Closed	-$729K	–	1207
2025 Q2	$729K	Buy	35,281 +12,728	+56%	+$261K	0.01%	701
2025 Q1	$442K	Buy	+22,553	New	+$473K	0.01%	579

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jain Global's GMAB Position: Q3 2025 in Review

Jain Global sold out of Genmab (GMAB) in Q3 2025, closing a stake of 35,281 shares — an estimated $729K sold.

Jain Global first reported a position in GMAB in Q1 2025 and held it in 2 quarters. The position peaked at $729K in Q2 2025. 252 funds tracked by Wall St. Rank hold GMAB as of Q3 2025.

Jain Global reported no remaining Genmab position as of Q3 2025 after selling out during the quarter.
Jain Global sold 35,281 Genmab shares in Q3 2025, an estimated $729K.
Jain Global first reported a position in Genmab in Q1 2025 and held it in 2 quarters.
Jain Global's Genmab position peaked at $729K in Q2 2025.
252 funds tracked by Wall St. Rank held Genmab as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.